Bacteriocin production by Bifidobacterium spp. A review

Biotechnology Advances

Volumn 31, Issue 4, 2013, Pages 482-488

  Martinez, Fabio Andres Castillo ^a   Balciunas, Eduardo Marcos ^a   Converti, Attilio ^b   Cotter, Paul D ^c   De Souza Oliveira, Ricardo Pinheiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF GENOA   (Italy)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Antimicrobial compounds; Bacteriocins; Bifidobacterium spp.; Lactic acid bacteria

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL COMPOUNDS; BACTERIOCINS; BIFIDOBACTERIUM; CLOSTRIDIUM PERFRINGENS; LACTIC ACID BACTERIA; PATHOGENIC MICROORGANISMS; PHARMACEUTICAL APPLICATIONS;

ESCHERICHIA COLI;

BACTERIA;

ANTIINFECTIVE AGENT; BACTERIOCIN;

ANTIMICROBIAL ACTIVITY; BACTERIOLOGY; BACTERIUM; BIOTECHNOLOGY; CLASSIFICATION; DISEASE TREATMENT; IMMUNITY; LITERATURE REVIEW; PATHOGEN; PEPTIDE; PROBIOTICS; PURIFICATION; TOXIN;

AMINO ACID SEQUENCE; BIFIDOBACTERIUM; BIOSYNTHESIS; CHEMISTRY; CLASSIFICATION; CULTURE MEDIUM; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; REVIEW;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; BIFIDOBACTERIUM; CULTURE MEDIA; MOLECULAR SEQUENCE DATA;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIUM PERFRINGENS; ESCHERICHIA COLI; LISTERIA MONOCYTOGENES;

EID: 84874958362     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2013.01.010     Document Type: Review

References (60)

1. Anand S.K., Srinivasan R.A., Rao L.K. Antimicrobial activity associated with Bifidobacterium bifidum-I. Cult Dairy Prod J 1984, 2:6-7.
2. Anand S.K., Srinivasan R.A., Rao L.K. Antibacterial activity associated with Bifidobacterium bifidum-II. Cult Dairy Prod J 1985, 2:21-23.
3. Ballongue J. Bifidobacteria and probiotic action. Lactic acid bacteria microbiological and functional aspects 2004, 67-124. Marcel Dekker Inc., New York. S. Salminen, A. von Wright, A. Ouwehand (Eds.).
4. Berjeaud J.M., Cenatiempo Y. Purification of antilisterial bacteriocins. Methods Mol Biol 2004, 268:225-233.
5. Bernet M.F., Brassart D., Neeser J.R., Servin A.L. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 1993, 59:4121-4128.
6. Bevilacqua L., Ovidi M., Di Mattia E., Trovatelli L.D., Canganella F. Screening of Bifidobacterium strains isolated from human faeces for antagonistic activities against potentially bacterial pathogens. Microbiol Res 2003, 158:179-185.
7. Bruno F., Shah N.P. Inhibition of pathogenic and putrefactive microorganisms by Bifidobacterium sp. Milchwissenschaft 2002, 57:617-621.
8. Carolissen-Mackay V., Arendse G., Hastings J.W. Purification of bacteriocins of lactic acid bacteria: problems and pointers. Int J Food Microbiol 1997, 34:1-16.
9. Cascales E., Buchanan S.K., Duché D., Kleanthous C., Lloubès R., Postle K., et al. Colicin biology. Microbiol Mol Biol Rev 2007, 71:158-229.
10. Cheikhyoussef A., Pogori N., Chen W., Zhang H. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int J Food Microbiol 2008, 125:215-222.
11. Cheikhyoussef A., Pogori N., Chen H., Tian F., Chen W., Tang J., et al. Antimicrobial activity and partial characterization of bacteriocin-like inhibitory substances (BLIS) produced by Bifidobacterium infantis BCRC 14602. Food Control 2009, 20:553-559.
12. Cheikhyoussef A., Pogori N., Chen H., Zhao J., Tang J., Chen W., et al. Comparison of three different methods for the isolation of bacteriocin-like inhibitory substances from Bifidobacterium infantis BCRC 14602. J Rapid Methods Autom Microbiol 2009, 17:182-194.
13. Cheikhyoussef A., Cheikhyoussef N., Chen H., Zhao J., Tang J., Zhang H., et al. Bifidin I - a new bacteriocin produced by Bifidobacterium infantis BCRC 14602: purification and partial amino acid sequence. Food Control 2010, 21:746-753.
14. Chou C.C., Hou J.W. Growth of bifidobacteria in soymilk and their survival in the fermented soymilk drink during storage. Int J Food Microbiol 2000, 56:113-121.
15. Collado M., González A., González R., Hernández M., Ferrús M., Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents 2005, 25:385-391.
16. Collado M., Hernández M., Sanz Y. Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. J Food Prot 2005, 68:1034-1040.
17. Cotter P.D., Hill C., Ross R.P. Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Protein Pept Sci 2005, 6:61-75.
18. Cotter P.D., Hill C., Ross R.P. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005, 3:777-788.
19. De Vries W., Stouthamer A.H. Pathway of glucose fermentation in relation to the taxonomy of bifidobacteria. J Bacteriol 1967, 93:574-576.
20. De Vuyst L., Leroy F. Bacteriocins from lactic acid bacteria: production, purification, and food applications. J Mol Microbiol Biotechnol 2007, 13:194-199.
21. Deegan L.H., Cotter P.D., Hill C., Ross P. Bacteriocins: biological tools for bio-preservation and shelf-life extension. Int Dairy J 2006, 16:1058-1071.
22. Deraz S.F., Karlsson E.N., Hedström M., Andersson M.M., Mattiasson B. Purification and characterisation of acidocin D20079, a bacteriocin produced by Lactobacillus acidophilus DSM 20079. J Biotechnol 2005, 117:343-354.
23. Dobson A., Cotter P.D., Ross R.P., Hill C. Bacteriocin production: a probiotic trait?. Appl Environ Microbiol 2012, 78:1-6.
24. Drider D., Fimland G., Héchard Y., Mcmullen L.M., Prévost H. The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 2006, 70:564-582.
25. Dubey U.K., Mistry V.V. Effect of bifidogenic factors on growth characteristics of bifidobacteria in infant formulas. J Dairy Sci 1996, 79:1156-1163.
26. Eijsink V.G.H., Axelsson L., Diep D.B., Håvarstein L.S., Holo H., Nes I.F. Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication. Antonie Van Leeuwenhoek 2002, 81:639-654.
27. Ennahar S., Sashihara T., Sonomoto K., Ishizaki A. Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 2000, 24:85-106.
28. FAO/WHO Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria 2001.
29. Gibson G., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994, 77:412-442.
30. Gibson G., Wang X. Bifidogenic properties of different types of fructo-oligosaccharides. Food Microbiol 1994, 11:491-498.
31. Gomes A.M., Malcata F.X. Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci Technol 1999, 10:139-157.
32. Ibrahim S., Salameh M. Simple and rapid method for screening antimicrobial activities of Bifidobacterium species of human isolates. J Rapid Methods Autom Microbiol 2001, 9:53-62.
33. Ishibashi N., Yaeshima T., Hayasawa H. Bifidobacteria: their significance in human intestinal health. Malays J Nutr 1997, 3:149-159.
34. Johnsen L., Fimland G., Nissen-Meyer J. The C-terminal domain of pediocin-like antimicrobial peptides (class IIa bacteriocins) is involved in specific recognition of the C-terminal part of cognate immunity proteins and in determining the antimicrobial spectrum. J Biol Chem 2005, 280:9243-9250.
35. Kang D., Fung D.C. Stimulation of starter culture for further reduction of foodborne pathogens during Salami fermentation. J Food Prot 2000, 63:1492-1495.
36. Kang K.H., Shin H.J., Park Y.H., Lee T.S. Studies on the antibacterial substances produced by lactic acid bacteria: purification and some properties of antibacterial substance "Bifilong" produced by B. longum. Korean Dairy Sci 1989, 1:204-216.
37. Klaenhammer T.R. Bacteriocins of lactic acid bacteria. Biochimie 1988, 70:337-349.
38. Kotelnikova E.A., Gelfand M.S. Bacteriocin production by Gram-positive bacteria and the mechanisms of transcriptional regulation. Russ J Genet 2002, 38:628-641.
39. Lee J.H., Karamychev V.N., Kozyavkin S.A., Mills D., Pavlov A.R., Pavlova N.V., et al. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 2008, 9:1-16.
40. Lee J.H., Li X., O'Sullivan D.J. Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A. Appl Environ Microbiol 2011, 77:5879-5887.
41. Li Q., Chen Q., Ruan H., Zhu D., He G. Isolation and characterisation of an oxygen, acid and bile resistant Bifidobacterium animalis subsp. lactis Qq08. J Sci Food Agric 2010, 90:1340-1346.
42. Liévin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.R., et al. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 2000, 47:646-652.
43. Lozano J.C.N., Meyer J.N., Sletten K., Peláz C., Nes I.F. Purification and amino acid sequence of a bacteriocin produced by Pediococcus acidilactici. J Gen Microbiol 1992, 138:1985-1990.
44. Makras L., De Vuyst L. The in vitro inhibition of Gram-negative pathogenic bacteria by bifidobacteria is caused by the production of organic acids. Int Dairy J 2006, 16:1049-1057.
45. Meghrous J., Euloge P., Junelles A.M., Ballongue J., Petitdemange H. Screening of Bifidobacterium strains for bacteriocin production. Biotechnol Lett 1990, 12:575-580.
46. Nebra Y., Blanch A.R. A new selective medium for Bifidobacterium spp. Appl Environ Microbiol 1999, 65:5173-5176.
47. O'Sullivan. Isolated bifidobacteria that produce siderophores which inhibit growth of Lactococcus lactis. United States patent 6746672. 2001.
48. O'Shea E.F., Cotter P.D., Stanton C., Ross R.P., Hill C. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol 2012, 15:189-205.
49. Pongtharangkul T., Demirci A. Evaluation of agar diffusion bioassay for nisin quantification. Appl Microbiol Biotechnol 2004, 65:268-272.
50. Riley M., Chavan M. Bacteriocins: ecology and evolution 2007, Springer, Heidelberg. 1st ed.
51. Riley M., Wertz J.E. Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 2002, 56:117-137.
52. Russell D.A., Ross R.P., Fitzgerald G.F., Stanton C. Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 2011, 14:88-105.
53. Saleh F.A., El-Sayed E.M. Isolation and characterization of bacteriocins produced by Bifidobacterium lactis BB-12 and Bifidobacterium longum BB-46. 9th Egyptian Conference for Dairy Science and Technology 2004, 323-337. Research Papers, Cairo.
54. Tagg J.R., Dajani A.S., Wannamaker L.W. Bacteriocins of Gram-positive bacteria. Bacteriol Rev 1976, 40:722-756.
55. Tissier H. Recherches sur la flore intestinale normale et pathologique du nourrisson (etat normale et pathologique). Paris: Thesis; 1900. p. 1-253.
56. Touré R., Kheadr E., Lacroix C., Moroni O., Fliss I. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J Appl Microbiol 2003, 95:1058-1069.
57. von Ah U. Identification of Bifidobacterium thermophilum RBL67 isolated from baby faeces and partial purification of its bacteriocin. Culture. Swiss Federal Institute of Technology. Zurich: PhD Thesis; 2006. p. 1-192.
58. Yang YS, Chen MC, Liao CC. Bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method. United States patent 5711977. 1998.
59. Yildirim Z., Johnson M. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. J Food Prot 1998, 61:47-51.
60. Yildirim Z., Winters D., Johnson M. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. J Appl Microbiol 1999, 86:45-54.